GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » Cyclically Adjusted Price-to-FCF

IDEXX Laboratories (WBO:IDXX) Cyclically Adjusted Price-to-FCF : 102.14 (As of May. 19, 2024)


View and export this data going back to 2017. Start your Free Trial

What is IDEXX Laboratories Cyclically Adjusted Price-to-FCF?

As of today (2024-05-19), IDEXX Laboratories's current share price is €497.40. IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €4.87. IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is 102.14.

The historical rank and industry rank for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

WBO:IDXX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 51.53   Med: 102.01   Max: 212.8
Current: 103.87

During the past years, IDEXX Laboratories's highest Cyclically Adjusted Price-to-FCF was 212.80. The lowest was 51.53. And the median was 102.01.

WBO:IDXX's Cyclically Adjusted Price-to-FCF is ranked worse than
87.1% of 62 companies
in the Medical Diagnostics & Research industry
Industry Median: 35.95 vs WBO:IDXX: 103.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IDEXX Laboratories's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €1.844. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €4.87 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for IDEXX Laboratories's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Cyclically Adjusted Price-to-FCF Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 112.49 176.12 182.37 99.18 111.70

IDEXX Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.83 110.59 91.33 111.70 103.19

Competitive Comparison of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted Price-to-FCF falls into.



IDEXX Laboratories Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

IDEXX Laboratories's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=497.40/4.87
=102.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, IDEXX Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.844/131.7762*131.7762
=1.844

Current CPI (Mar. 2024) = 131.7762.

IDEXX Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.481 100.560 0.630
201409 0.586 100.428 0.769
201412 0.078 99.070 0.104
201503 -0.364 99.621 -0.481
201506 0.532 100.684 0.696
201509 0.540 100.392 0.709
201512 0.639 99.792 0.844
201603 0.050 100.470 0.066
201606 0.930 101.688 1.205
201609 0.863 101.861 1.116
201612 0.899 101.863 1.163
201703 0.079 102.862 0.101
201706 0.943 103.349 1.202
201709 0.889 104.136 1.125
201712 0.940 104.011 1.191
201803 0.102 105.290 0.128
201806 0.881 106.317 1.092
201809 0.765 106.507 0.947
201812 0.959 105.998 1.192
201903 -0.039 107.251 -0.048
201906 1.044 108.070 1.273
201909 0.983 108.329 1.196
201912 1.129 108.420 1.372
202003 -0.228 108.902 -0.276
202006 1.887 108.767 2.286
202009 1.701 109.815 2.041
202012 1.935 109.897 2.320
202103 1.008 111.754 1.189
202106 2.025 114.631 2.328
202109 1.397 115.734 1.591
202112 1.830 117.630 2.050
202203 0.773 121.301 0.840
202206 0.399 125.017 0.421
202209 1.817 125.227 1.912
202212 1.399 125.222 1.472
202303 1.606 127.348 1.662
202306 1.900 128.729 1.945
202309 2.659 129.860 2.698
202312 2.374 129.419 2.417
202403 1.844 131.776 1.844

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IDEXX Laboratories  (WBO:IDXX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


IDEXX Laboratories Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories (WBO:IDXX) Business Description

Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.